Table 1.
Clinical Features | XP | XP Neurological Disease | XP/CS | CS |
---|---|---|---|---|
Molecular defects | XP-A, -B, -C, -D, -E, -F and XP-V | XP-A and XP-D followed by XP-B, XP-G, and XP-F | XP-B, XP-D, XP-G | CS-A, CS-B |
Skin sun sensitivity | + | + | + | + |
Increased freckling | + | + | + | - |
Sunlight—induced skin cancer | + | + | + | - |
Photophobia | + | + | + | + |
Anterior eye cancer | + | + | + | - |
Retinal degeneration | - | - | + | + |
Sensorineural deafness | - | + | + | + |
Developmental delay | - | + | + | + |
Progressive neurological degeneration | - | + | + | + |
Primary neuronal degeneration | - | + | - | - |
Demyelination of brain | - | - | + | + |
Cerebral atrophy | - | + | + | + |
Cerebellar atrophy | - | + | + | + |
Calcification (basal ganglia) | - | - | + | + |
“+”—indicated clinical feature is associated with the disease; “-”—this clinical feature does not observed.